Literature DB >> 31767976

HBsAg-specific CD8+ T cells as an indispensable trigger to induce murine hepatocellular carcinoma.

Xiaolei Hao1,2, Yongyan Chen1,2, Lu Bai1,2, Haiming Wei1,2, Rui Sun3,4, Zhigang Tian5,6.   

Abstract

Hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) is mediated by an inappropriate attack by HBV-specific T cells in patients. However, this immunopathogenic process has not been clarified because of the lack of a suitable animal model. Here, we used immunocompetent Fah-/- mice as the recipients in the adoptive transfer of HBsAg+ hepatocytes from HBs-Tg mice to replace the recipient hepatocytes (HBs-HepR). HBs-HepR mice exhibited persistent HBsAg expression with chronic hepatitis and eventually developed HCC with a prevalence of 100%. HBsAg-specific CD8+ T cells were generated and specifically and continuously induced hepatocyte apoptosis with progressive chronic inflammation, and the depletion of CD8+ T cells or their deficiency prevented HCC, which could then be reproduced by the transfer of HBsAg-specific CD8+ T cells. In summary, our results demonstrated that CD8+ T cells plays a critical role in HBsAg-driven inflammtion and HCC tumorigenesis.

Entities:  

Keywords:  HBV; HBsAg-specific CTL; HCC

Mesh:

Substances:

Year:  2019        PMID: 31767976      PMCID: PMC7853119          DOI: 10.1038/s41423-019-0330-1

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  47 in total

1.  Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.

Authors:  L G Guidotti; T Ishikawa; M V Hobbs; B Matzke; R Schreiber; F V Chisari
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

Review 2.  Adaptive immunity in HBV infection.

Authors:  Antonio Bertoletti; Carlo Ferrari
Journal:  J Hepatol       Date:  2016-04       Impact factor: 25.083

Review 3.  The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective.

Authors:  Alan P Venook; Christos Papandreou; Junji Furuse; Laura Ladrón de Guevara
Journal:  Oncologist       Date:  2010

4.  Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.

Authors:  Wing-Kin Sung; Hancheng Zheng; Shuyu Li; Ronghua Chen; Xiao Liu; Yingrui Li; Nikki P Lee; Wah H Lee; Pramila N Ariyaratne; Chandana Tennakoon; Fabianus H Mulawadi; Kwong F Wong; Angela M Liu; Ronnie T Poon; Sheung Tat Fan; Kwong L Chan; Zhuolin Gong; Yujie Hu; Zhao Lin; Guan Wang; Qinghui Zhang; Thomas D Barber; Wen-Chi Chou; Amit Aggarwal; Ke Hao; Wei Zhou; Chunsheng Zhang; James Hardwick; Carolyn Buser; Jiangchun Xu; Zhengyan Kan; Hongyue Dai; Mao Mao; Christoph Reinhard; Jun Wang; John M Luk
Journal:  Nat Genet       Date:  2012-05-27       Impact factor: 38.330

Review 5.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

Authors:  Hashem B El-Serag; K Lenhard Rudolph
Journal:  Gastroenterology       Date:  2007-06       Impact factor: 22.682

6.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

7.  The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.

Authors:  M K Maini; C Boni; C K Lee; J R Larrubia; S Reignat; G S Ogg; A S King; J Herberg; R Gilson; A Alisa; R Williams; D Vergani; N V Naoumov; C Ferrari; A Bertoletti
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

8.  Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas.

Authors:  Giuliana Amaddeo; Qian Cao; Yannick Ladeiro; Sandrine Imbeaud; Jean-Charles Nault; Daphne Jaoui; Yann Gaston Mathe; Christophe Laurent; Alexis Laurent; Paulette Bioulac-Sage; Julien Calderaro; Jessica Zucman-Rossi
Journal:  Gut       Date:  2014-06-09       Impact factor: 23.059

9.  Immune pathogenesis of hepatocellular carcinoma.

Authors:  Y Nakamoto; L G Guidotti; C V Kuhlen; P Fowler; F V Chisari
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

10.  Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.

Authors:  K Ando; T Moriyama; L G Guidotti; S Wirth; R D Schreiber; H J Schlicht; S N Huang; F V Chisari
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  6 in total

1.  Transcriptomic characteristics and impaired immune function of patients who retest positive for SARS-CoV-2 RNA.

Authors:  Dongyao Wang; Dong Wang; Min Huang; Xiaohu Zheng; Yiqing Shen; Binqing Fu; Hong Zhao; Xianxiang Chen; Peng Peng; Qi Zhu; Yonggang Zhou; Jinghe Zhang; Zhigang Tian; Wuxiang Guan; Guiqiang Wang; Haiming Wei
Journal:  J Mol Cell Biol       Date:  2021-12-30       Impact factor: 6.216

2.  Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia.

Authors:  Xinhui Wang; Xiaoli Liu; Peng Wang; Lihua Yu; Fengna Yan; Huiwen Yan; Dongdong Zhou; Zhiyun Yang
Journal:  J Hepatocell Carcinoma       Date:  2021-10-21

Review 3.  Targeting mitochondrial quality control of T cells: Regulating the immune response in HCC.

Authors:  Yixue Xia; Binghong Gao; Xue Zhang
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

4.  HBV immune tolerance of HBs-transgenic mice observed through parabiosis with WT mice.

Authors:  Wendi Zhang; Haoyu Sun; Rui Sun; Zhexiong Lian; Haiming Wei; Zhigang Tian; Yongyan Chen
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

5.  Computational Design of a Novel VLP-Based Vaccine for Hepatitis B Virus.

Authors:  Saeed Mobini; Milad Chizari; Ladan Mafakher; Elmira Rismani; Elham Rismani
Journal:  Front Immunol       Date:  2020-08-27       Impact factor: 7.561

6.  Mesencephalic astrocyte-derived neurotrophic factor reprograms macrophages to ameliorate acetaminophen-induced acute liver injury via p38 MAPK pathway.

Authors:  Xin Hou; Qi Liu; Yimin Gao; Liang Yong; Huiyuan Xie; Wenting Li; Yuping Zhou; Jun Liu; Lijie Feng; Long Xu; Yuxian Shen; Hua Wang
Journal:  Cell Death Dis       Date:  2022-02-02       Impact factor: 9.685

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.